United Guardian (UG) EV to CFO (2010 - 2026)
United Guardian's (UG) quarterly EV to CFO came in at 15.27 in Q2 2026, down 83.66% year-over-year from 93.43 in Q2 2025, and down 59.42% quarter-over-quarter from 37.63 in Q1 2026.
Analysis
United Guardian (UG) EV to CFO (2010 - 2026) Analysis & Trends
United Guardian has disclosed EV to CFO across 17 years of filings, most recently posting 15.27 for Q2 2026.
- In Q2 2026, EV to CFO fell 83.66% year-over-year to 15.27; the TTM figure through Jun 2026 stood at 6.7 (down 49.82% YoY), while the FY2025 annual figure was 10.03, up 0.7% from the prior year.
- EV to CFO came in at 15.27 for Q2 2026 at United Guardian, down from 37.63 in the prior quarter.
- In the past five years, EV to CFO ranged from a high of 3526.51 in Q1 2022 to a low of 15.27 in Q2 2026.
- Average EV to CFO over 5 years is 247.86, with a median of 57.15 recorded in 2022.
- Year-over-year, EV to CFO soared 5668.88% in 2022 and sank 97.54% in 2023.
- Over 5 years, EV to CFO stood at 66.4 in 2022, then plunged by 75.84% to 16.04 in 2023, then jumped by 699.11% to 128.2 in 2024, then tumbled by 53.44% to 59.69 in 2025, then slumped by 74.42% to 15.27 in 2026.
- Per Business Quant data, the three most recent EV to CFO figures were 15.27 in Q2 2026, 37.63 in Q1 2026, and 59.69 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.03 Bn | 625.27 Bn | 17.26 Bn |
| 2 | AbbVie | 441.56 Bn | 434.99 Bn | 12.70 Bn |
| 3 | Merck | 364.45 Bn | 357.31 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.46 Bn | 259.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.77 Bn | 147.08 Bn | 10.94 Bn |
| 6 | Sanofi | 52.48 Bn | 45.10 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.15 Bn | 44.15 Bn | - |
| 8 | Incyte | 25.31 Bn | 20.77 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.29 Bn | 18.63 Bn | 683.80 Mn |
| 10 | United Guardian | 33.07 Mn | 23.48 Mn | 1.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.27 |
| Mar 31, 2026 | 37.63 |
| Dec 31, 2025 | 59.69 |
| Sep 30, 2025 | 27.50 |
| Jun 30, 2025 | 93.43 |
| Mar 31, 2025 | 103.02 |
| Dec 31, 2024 | 128.20 |
| Sep 30, 2024 | 51.65 |
| Jun 30, 2024 | 19.35 |
| Mar 31, 2024 | 33.90 |
| Dec 31, 2023 | 16.04 |
| Sep 30, 2023 | 18.70 |
| Jun 30, 2023 | 61.65 |
| Mar 31, 2023 | 86.72 |
| Dec 31, 2022 | 66.40 |
| Sep 30, 2022 | 61.21 |
| Jun 30, 2022 | 54.61 |
| Mar 31, 2022 | 3,526.51 |
| Dec 31, 2021 | 40.50 |
| Sep 30, 2021 | 53.96 |